These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 16634896)
1. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans. Kubo M; Ihn H; Yamane K; Tamaki K Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896 [TBL] [Abstract][Full Text] [Related]
2. The expression levels of thrombospondin-1 in dermatofibroma and dermatofibrosarcoma protuberans. Maekawa T; Jinnin M; Ohtsuki M; Ihn H Eur J Dermatol; 2011; 21(4):534-8. PubMed ID: 21697041 [TBL] [Abstract][Full Text] [Related]
3. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy. Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988 [TBL] [Abstract][Full Text] [Related]
4. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis. Kubo M; Ihn H; Yamane K; Tamaki K J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152 [TBL] [Abstract][Full Text] [Related]
5. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa. Kahn HJ; Fekete E; From L Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295 [TBL] [Abstract][Full Text] [Related]
6. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis. Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710 [TBL] [Abstract][Full Text] [Related]
7. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34. Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171 [TBL] [Abstract][Full Text] [Related]
8. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma. Mori T; Misago N; Yamamoto O; Toda S; Narisawa Y J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829 [TBL] [Abstract][Full Text] [Related]
9. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas. Schmid P; Itin P; Rufli T Br J Dermatol; 1996 Jun; 134(6):1044-51. PubMed ID: 8763422 [TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor beta isoforms and their receptors in malignant fibrous histiocytoma of soft tissues. Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Nakatani T; Kurosaka M Clin Cancer Res; 2004 Sep; 10(17):5804-7. PubMed ID: 15355909 [TBL] [Abstract][Full Text] [Related]
12. Collagen triple helix repeat containing-1 in the differential diagnosis of dermatofibrosarcoma protuberans and dermatofibroma. Wang L; Xiang YN; Zhang YH; Tu YT; Chen HX Br J Dermatol; 2011 Jan; 164(1):135-40. PubMed ID: 20849518 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma. Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633 [TBL] [Abstract][Full Text] [Related]
14. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427 [TBL] [Abstract][Full Text] [Related]
15. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1). Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related]
17. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120 [TBL] [Abstract][Full Text] [Related]
18. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds. Cowin AJ; Holmes TM; Brosnan P; Ferguson MW Eur J Dermatol; 2001; 11(5):424-31. PubMed ID: 11525949 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation. Jakowlew SB; Moody TW; Mariano JM Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635 [TBL] [Abstract][Full Text] [Related]
20. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma. Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]